The characterization of the invasion phenotype of uveal melanoma tumour cells shows the presence of MUC18 and HMG‐1 metastasis markers and leads to the identification of DJ‐1 as a potential serum biomarker

Uveal malignant melanoma (UM) is the most frequent primary intraocular tumour in adult humans. Because the survival rate of patients with UM has changed little in the past few decades, a better understanding of the molecular events governing UM development and the identification of markers indicating the potential for metastasis at the time of diagnosis are necessary to design improved and more specific treatments. In this study, we investigated UM tumour development by comparing two recently established UM cultures with different invasion potential by two‐dimensional gel electrophoresis. Protein features expressed differentially were identified by mass spectrometric analysis. Potential markers were assayed in both cultures and in long‐term established UM cell lines (UW‐1, OCM‐1, SP6.5 and 92.1) by Western blotting and their role in invasion analysed using Matrigel membranes. Comparative analysis revealed that UM cultures with low‐ and high‐grade invasion potential differ in their cellular metabolism and, more interestingly, in several cancer‐associated proteins, including those implicated in cell adhesion and migration, proliferation and various oncogenes. Our data indicate a correlation between MUC18 and HMG‐1 expression and the invasiveness of UM cells. We also demonstrate the expression and secretion of DJ‐1 oncoprotein by UM cells. We suggest a possible role for MUC18 and HMG‐1 proteins in UM cell invasion. The secretion of DJ‐1 by UM cells, and the ability to detect this protein in UM patients' sera implicate it as a potential noninvasive biomarker for this malignancy. © 2006 Wiley‐Liss, Inc.

[1]  R. Dwek,et al.  Proteome analysis of a human uveal melanoma primary cell culture by 2‐DE and MS , 2005, Proteomics.

[2]  M. Karas,et al.  Use of two‐dimensional gel electrophoresis in predictive toxicology: Identification of potential early protein biomarkers in chemically induced hepatocarcinogenesis , 2005, Proteomics.

[3]  Arun D. Singh,et al.  Metastatic uveal melanoma. , 2005, Ophthalmology clinics of North America.

[4]  N. Iizuka,et al.  Proteomic profiling for cancer progression: Differential display analysis for the expression of intracellular proteins between regressive and progressive cancer cell lines , 2005, Proteomics.

[5]  T. Mak,et al.  DJ-1, a novel regulator of the tumor suppressor PTEN. , 2005, Cancer cell.

[6]  M. T. de la Fuente,et al.  Abnormal cell cycle regulation in primary human uveal melanoma cultures , 2004, Journal of cellular biochemistry.

[7]  B. Davies,et al.  High‐mobility group protein 1(Y): Metastasis‐associated or metastasis‐inducing? , 2004, Journal of surgical oncology.

[8]  Virginia Espina,et al.  Genomic and proteomic technologies for individualisation and improvement of cancer treatment. , 2004, European journal of cancer.

[9]  Justis P. Ehlers,et al.  Gene Expression Profiling in Uveal Melanoma Reveals Two Molecular Classes and Predicts Metastatic Death , 2004, Cancer Research.

[10]  Tadashi Kondo,et al.  Proteomic signature of human cancer cells , 2004, Proteomics.

[11]  Y. Hod Differential control of apoptosis by DJ‐1 in prostate benign and cancer cells , 2004, Journal of cellular biochemistry.

[12]  Mark A. Wilson,et al.  The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[13]  J. Marshall,et al.  How in vitro techniques have increased our understanding of uveal melanoma cellular biology. , 2004, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.

[14]  M. Burnier,et al.  New prognostic factors in uveal melanomas: potential molecular targets for therapy. , 2004, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.

[15]  C. Baudouin,et al.  Comparison of morphological and functional characteristics of primary-cultured human conjunctival epithelium and of Wong-Kilbourne derivative of Chang conjunctival cell line. , 2004, Experimental eye research.

[16]  J. Rodrigo,et al.  Annexin A1 down-regulation in head and neck cancer is associated with epithelial differentiation status. , 2004, The American journal of pathology.

[17]  Li Mao,et al.  Identification and validation of metastasis-associated proteins in head and neck cancer cell lines by two-dimensional electrophoresis and mass spectrometry , 2004, Clinical & Experimental Metastasis.

[18]  D. Theodorescu,et al.  The relationship of BRMS1 and RhoGDI2 gene expression to metastatic potential in lineage related human bladder cancer cell lines , 2004, Clinical & Experimental Metastasis.

[19]  P. Meltzer,et al.  Molecular determinants of human uveal melanoma invasion and metastasis , 2004, Clinical & Experimental Metastasis.

[20]  Y. Hod,et al.  Proteomic profiling drug-induced apoptosis in non-small cell lung carcinoma: identification of RS/DJ-1 and RhoGDIalpha. , 2003, Cancer research.

[21]  B. Oostra,et al.  DJ-1( PARK7), a novel gene for autosomal recessive, early onset parkinsonism , 2003, Neurological Sciences.

[22]  K. Jöckel,et al.  Tumor classification based on gene expression profiling shows that uveal melanomas with and without monosomy 3 represent two distinct entities. , 2003, Cancer research.

[23]  Arun D. Singh,et al.  Survival rates with uveal melanoma in the United States: 1973-1997. , 2003, Ophthalmology.

[24]  T. Niki,et al.  DJBP: a novel DJ-1-binding protein, negatively regulates the androgen receptor by recruiting histone deacetylase complex, and DJ-1 antagonizes this inhibition by abrogation of this complex. , 2003, Molecular cancer research : MCR.

[25]  R. E. Kalina,et al.  Immunophenotype of conjunctival melanomas: comparisons with uveal and cutaneous melanomas. , 2002, Archives of ophthalmology.

[26]  Suyun Huang,et al.  Fully human antibodies to MCAM/MUC18 inhibit tumor growth and metastasis of human melanoma. , 2002, Cancer research.

[27]  D. Lev,et al.  Cellular Adhesion Pathways and Metastatic Potential of Human Melanoma , 2002, Cancer biology & therapy.

[28]  Kun Wang,et al.  Advantages of in vitro cytotoxicity testing by using primary rat hepatocytes in comparison with established cell lines. , 2002, The Journal of toxicological sciences.

[29]  T. Niki,et al.  DJ-1, a target protein for an endocrine disrupter, participates in the fertilization in mice. , 2002, Biological & pharmaceutical bulletin.

[30]  David E. Misek,et al.  Discordant Protein and mRNA Expression in Lung Adenocarcinomas * , 2002, Molecular & Cellular Proteomics.

[31]  R. Dwek,et al.  Towards complete analysis of the platelet proteome , 2002, Proteomics.

[32]  Ahmedin Jemal,et al.  Cancer Statistics, 2002 , 2002, CA: a cancer journal for clinicians.

[33]  M. Amin,et al.  Isolation and characterization of the major form of human MUC18 cDNA gene and correlation of MUC18 over-expression in prostate cancer cell lines and tissues with malignant progression. , 2001, Gene.

[34]  David E. Misek,et al.  Proteomics-based identification of RS/DJ-1 as a novel circulating tumor antigen in breast cancer. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[35]  S Hanash,et al.  Proteomics in early detection of cancer. , 2001, Clinical chemistry.

[36]  C. Korch,et al.  TSU-Pr1 and JCA-1 cells are derivatives of T24 bladder carcinoma cells and are not of prostatic origin. , 2001, Cancer research.

[37]  R. Reeves,et al.  Architectural Transcription Factor HMGI(Y) Promotes Tumor Progression and Mesenchymal Transition of Human Epithelial Cells , 2001, Molecular and Cellular Biology.

[38]  T. Kivelä,et al.  Tumor doubling times in metastatic malignant melanoma of the uvea: tumor progression before and after treatment. , 2000, Ophthalmology.

[39]  D. Botstein,et al.  A gene expression database for the molecular pharmacology of cancer , 2000, Nature Genetics.

[40]  Christian A. Rees,et al.  Systematic variation in gene expression patterns in human cancer cell lines , 2000, Nature Genetics.

[41]  A. Heiligenhaus,et al.  Expression of the Cell Adhesion Molecules ICAM-1, VCAM-1 and NCAM in Uveal Melanoma: A Clinicopathological Study , 2000, Oncology.

[42]  I. Shih The role of CD146 (Mel‐CAM) in biology and pathology , 1999, The Journal of pathology.

[43]  M. Hendrix,et al.  Biologic determinants of uveal melanoma metastatic phenotype: role of intermediate filaments as predictive markers. , 1998, Laboratory investigation; a journal of technical methods and pathology.

[44]  M. Saornil,et al.  Morphologic and immunocytochemical characterization of four human uveal cell lines (melanoma- and melanocytes-derived). , 1997, Current eye research.

[45]  T. Taira,et al.  DJ-1, a novel oncogene which transforms mouse NIH3T3 cells in cooperation with ras. , 1997, Biochemical and biophysical research communications.

[46]  D. Hochstrasser,et al.  Improved and simplified in‐gel sample application using reswelling of dry immobilized pH gradients , 1997, Electrophoresis.

[47]  A. Podtelejnikov,et al.  Linking genome and proteome by mass spectrometry: large-scale identification of yeast proteins from two dimensional gels. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[48]  A. Hanby,et al.  Identification by differential display of annexin-VI, a gene differentially expressed during melanoma progression. , 1996, Cancer research.

[49]  J. Sampol,et al.  Identification of the S-Endo 1 endothelial-associated antigen. , 1996, Biochemical and biophysical research communications.

[50]  K. Hayasaka,et al.  Suppression of calphobindin I (CPB I) production in carcinoma of uterine cervix and endometrium. , 1995, Gynecologic oncology.

[51]  L. Romer,et al.  EndoCAM: a novel endothelial cell-cell adhesion molecule , 1990, The Journal of cell biology.

[52]  J. Lehmann,et al.  MUC18, a marker of tumor progression in human melanoma, shows sequence similarity to the neural cell adhesion molecules of the immunoglobulin superfamily. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[53]  A. Balmain,et al.  Analysis of the HMGI nuclear proteins in mouse neoplastic cells induced by different procedures. , 1989, Experimental cell research.

[54]  N. Dubrawsky Cancer statistics , 1989, CA: a cancer journal for clinicians.

[55]  L. Loew,et al.  Charge-shift probes of membrane potential. Synthesis , 1984 .